HUMAN ISLET ANTGEN DISCOVERY AND IMAGING
人类胰岛抗原的发现和成像
基本信息
- 批准号:8326435
- 负责人:
- 金额:$ 5.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-30 至 2013-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAreaAssesBeta CellBindingBiochemistryBiological MarkersBiologyCellsClinicalDataDiabetes MellitusDiagnosisDiseaseDisease ProgressionDrug IndustryDrug or chemical Tissue DistributionEGF geneEndocrineEvaluationExocrine pancreasFunctional disorderGastrinsGenesGlucagonGoldGrowth and Development functionHeadHead of pancreasHealthHealth ProfessionalHumanHyperglycemiaImageImaging TechniquesIncidenceInsulinInsulin ResistanceInsulin-Dependent Diabetes MellitusInterventionInvestigationIslets of LangerhansLigandsLiteratureLobeLongitudinal StudiesMeasurableMeasurementMeasuresMetabolicMethodsMinorModelingMonitorNatural regenerationNon-Insulin-Dependent Diabetes MellitusObesityPancreasPancreatic PolypeptidePathologyPatientsPharmaceutical PreparationsPopulationPositron-Emission TomographyPre-Clinical ModelRattusRegulatory ElementRelative (related person)Research DesignRodentRodent ModelSeriesSignal TransductionSomatostatinStaining methodStainsStructure of beta Cell of isletTechniquesTimeTissuesWorkbasediabetes mellitus therapydiabeticfallsglucose tolerancein vivoinsightinsulin secretionisletlongitudinal positron emission tomographymeetingsmorphometrynanopreclinical studypromoterradioligandreceptorresearch clinical testingresearch studytype I and type II diabetesuptakevesicular monoamine transporter
项目摘要
DESCRIPTION (provided by applicant): The common pathology underlying both type 1 and type 2 diabetes (T1D and T2D) is insufficient beta-cell mass (BCM) to meet metabolic demands. An important impediment to the more rapid evaluation of interventions for both T1D and T2D is lack of suitable biomarkers of pancreatic beta cell mass. A reliable means of monitoring the mass and/or function of beta cells would enable evaluation of the progression of diabetes in real time as well as the monitoring the efficacy of pharmacologic and other interventions. This proposal addresses these needs. Recently, we identified a biomarker of beta cell mass that is quantifiable in vivo by Positron Emission Tomography (PET). PET is a tomographic imaging technique, which allows for accurate non-invasive in vivo dynamic measurements of regional radioligand uptake and clearance. These dynamic measurements of specific radiolabled compounds are sensitive in the pico- to nano-molar range and can be deconvoluted into measurements of receptor concentration. For beta cell mass estimates, we have identified VMAT2 (vesicular monoamine transporter type 2) as the biomarker and DTBZ as the transporter's ligand. VMAT2 is highly expressed in beta cells of the human pancreas relative to other cells of the endocrine and exocrine pancreas. Thus dynamic measurements of the uptake and clearance of DTBZ radioligands in the pancreas provide a measure of VMAT2 concentrations and an indirect measurement of beta cell mass. The primary aim of this renewal application is to better understand the biology and biochemistry of VMAT2 in beta cells and to provide further evidence of the clinical utility of PET scans using preclinical models of progression of T2D and therapy of T1D and T2D. In Specific Aim One we propose longitudinal studies using PET to estimate beta cell mass in a rodent models of T2D. These studies are designed to understand how estimates of BCM made PET scans with [18F]-FP-DTBZ perform under metabolic perturbations of beta cell mass and function. In Specific Aim Two, using insights developed in Aim one, we will analyze PET imaging of beta cells in the context of beta cell regeneration. In Specific Aim Three, we will study the tissue distribution of VMAT2 in a unique area of the human pancreas, the posterior lobe of the head, where VMAT2 expression may extend to cells expressing pancreatic polypeptide. In this Aim we will quantitate the co-expression of VMAT2 and pancreatic polypeptide to determine how far astray VMAT2 falls from being the "perfect" beta cell biomarker. Overall, the proposed studies in Aims one, two and three constitute the next logical next steps in our ongoing clinical evaluation of the use of VMAT2 as biomarker of BCM in human health and disease. PUBLIC HEALTH RELEVANCE: The rising world-wide incidence of diabetes, combined with the lack of suitable endpoints of the body's measurable and true capacity to produce insulin, constitute a serious restriction facing health care professionals and the pharmaceutical industry. Recently, we identified a biomarker of beta cell mass that is quantifiable in vivo by PET. This application proposes a series of studies aimed at validating the utility of this technique in monitoring diabetic disease progression in a non-invasive real time manner. The ability to noninvasively measure the mass of insulin producing beta cells will be of critical value towards characterizing new drugs and refining the diagnosis and treatment of this devastating disease.
描述(申请人提供):1型和2型糖尿病(T1D和T2D)的常见病理基础是β细胞质量(BCM)不足,无法满足代谢需求。对T1D和T2D干预措施进行更快速评估的一个重要障碍是缺乏合适的胰岛β细胞团生物标志物。监测β细胞质量和/或功能的可靠手段将能够实时评估糖尿病的进展以及监测药物和其他干预措施的效果。这项建议满足了这些需求。最近,我们发现了一种可以通过正电子发射断层扫描(PET)在体内定量的β细胞质量的生物标志物。PET是一种断层成像技术,它可以在体内无创地动态测量局部放射性配基的摄取和清除。这些对特定放射性化合物的动态测量在微微到纳米摩尔范围内是灵敏的,并且可以解卷积成受体浓度的测量。对于β细胞质量的估计,我们已经确定VMAT2(囊泡单胺转运体类型2)为生物标记物,DTBZ作为转运体的配体。相对于内分泌和外分泌胰腺的其他细胞,VMAT2在人胰腺的β细胞中高表达。因此,动态测量胰腺中DTBZ放射性配基的摄取和清除提供了VMAT2浓度的测量和β细胞质量的间接测量。这一更新应用的主要目的是更好地了解VMAT2在β细胞中的生物学和生化,并使用T2D进展的临床前模型和T1D和T2D的治疗为PET扫描的临床应用提供进一步的证据。在具体目标一中,我们建议使用正电子发射计算机断层扫描(PET)进行纵向研究,以估计T2D啮齿动物模型中的β细胞质量。这些研究旨在了解BCM使用[18F]-FP-DTBZ进行PET扫描的估计如何在β细胞质量和功能的代谢扰动下执行。在具体的目标二中,利用目标一中提出的见解,我们将在贝塔细胞再生的背景下分析贝塔细胞的PET成像。在特定的目标三中,我们将研究VMAT2在人胰腺一个独特的区域--头部后叶的组织分布,在那里VMAT2的表达可能延伸到表达胰腺多肽的细胞。在这个目标中,我们将对VMAT2和胰多肽的共表达进行量化,以确定VMAT2距离成为“完美”的β细胞生物标记物还有多远。总体而言,目标一、目标二和目标三中建议的研究构成了我们正在进行的VMAT2作为BCM生物标记物在人类健康和疾病中的使用的临床评估的下一个合乎逻辑的下一步。与公共卫生相关:世界范围内糖尿病发病率的上升,再加上人体可测量和真实产生胰岛素的能力缺乏合适的终点,构成了卫生保健专业人员和制药业面临的严重限制。最近,我们发现了一种可在活体内用正电子发射计算机断层扫描(PET)进行定量的β细胞质量的生物标志物。本申请提出了一系列研究,旨在验证该技术在以非侵入性实时方式监测糖尿病疾病进展方面的实用性。非侵入性地测量产生胰岛素的β细胞数量的能力将对确定新药的特征以及改进这种毁灭性疾病的诊断和治疗具有关键价值。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul E Harris其他文献
Paul E Harris的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul E Harris', 18)}}的其他基金
相似国自然基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
- 批准号:2021JJ40433
- 批准年份:2021
- 资助金额:0.0 万元
- 项目类别:省市级项目
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
- 批准号:32001603
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
AREA国际经济模型的移植.改进和应用
- 批准号:18870435
- 批准年份:1988
- 资助金额:2.0 万元
- 项目类别:面上项目
相似海外基金
Onboarding Rural Area Mathematics and Physical Science Scholars
农村地区数学和物理科学学者的入职
- 批准号:
2322614 - 财政年份:2024
- 资助金额:
$ 5.87万 - 项目类别:
Standard Grant
Point-scanning confocal with area detector
点扫描共焦与区域检测器
- 批准号:
534092360 - 财政年份:2024
- 资助金额:
$ 5.87万 - 项目类别:
Major Research Instrumentation
TRACK-UK: Synthesized Census and Small Area Statistics for Transport and Energy
TRACK-UK:交通和能源综合人口普查和小区域统计
- 批准号:
ES/Z50290X/1 - 财政年份:2024
- 资助金额:
$ 5.87万 - 项目类别:
Research Grant
Wide-area low-cost sustainable ocean temperature and velocity structure extraction using distributed fibre optic sensing within legacy seafloor cables
使用传统海底电缆中的分布式光纤传感进行广域低成本可持续海洋温度和速度结构提取
- 批准号:
NE/Y003365/1 - 财政年份:2024
- 资助金额:
$ 5.87万 - 项目类别:
Research Grant
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326714 - 财政年份:2024
- 资助金额:
$ 5.87万 - 项目类别:
Standard Grant
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326713 - 财政年份:2024
- 资助金额:
$ 5.87万 - 项目类别:
Standard Grant
Unlicensed Low-Power Wide Area Networks for Location-based Services
用于基于位置的服务的免许可低功耗广域网
- 批准号:
24K20765 - 财政年份:2024
- 资助金额:
$ 5.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427233 - 财政年份:2024
- 资助金额:
$ 5.87万 - 项目类别:
Standard Grant
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427232 - 财政年份:2024
- 资助金额:
$ 5.87万 - 项目类别:
Standard Grant
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427231 - 财政年份:2024
- 资助金额:
$ 5.87万 - 项目类别:
Standard Grant